Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555825 · ClinicalTrials.gov registry record · Phase 3
Burke-Hocoma Efficiency Study
A Phase 3 study of Hemiparesis and Hemiplegia, sponsored by Burke Medical Research Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT03555825 is a Phase 3 study of Hemiparesis and Hemiplegia that has completed, run by Burke Medical Research Institute. The registered enrollment target is 47 participants, below the 58-participant average among 22 other Hemiparesis trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03555825, a Phase 3 study of Hemiparesis and Hemiplegia, has completed, sponsored by Burke Medical Research Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
The ArmeoSpring device is an exoskeleton (3 joints and 6 degrees of freedom) with integrated springs. The investigators hypothesize that 3 days of training for 6 weeks with the Hocoma Armeo Spring device will be efficient and more effective than one on one ArmeoSpring therapy.
Conditions Studied
Interventions
- DEVICE Hocoma ArmeoSpring
Study Locations (1)
New York
- Burke Medical Research Institute - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-05-01 |
| Est. Completion | 2020-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03555825
The ClinicalTrials.gov registry entry for NCT03555825 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 22 other Hemiparesis trials with a reported enrollment target (19% lower). The listed sponsor is Burke Medical Research Institute, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hemiparesis appearing as the primary indexed condition, and to 1 intervention - of which Hocoma ArmeoSpring is the first listed.
NCT03555825 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03555825 about?
NCT03555825 is a clinical study titled "Burke-Hocoma Efficiency Study". The ArmeoSpring device is an exoskeleton (3 joints and 6 degrees of freedom) with integrated springs. The investigators hypothesize that 3 days of training for 6 weeks with the Hocoma Armeo Spring device will be efficient and more effective than one on one ArmeoSpring therapy.
What is the current status of trial NCT03555825?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 47 participants. The study started on 2016-05-01. Estimated completion is 2020-12.
What conditions does trial NCT03555825 study?
This clinical trial studies the following conditions: Hemiparesis, Hemiplegia.
What interventions are being tested in trial NCT03555825?
The interventions under investigation include: Hocoma ArmeoSpring (DEVICE).
Who is sponsoring clinical trial NCT03555825?
This trial is sponsored by Burke Medical Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03555825 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemiparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanisms of Open and Hidden Placebo in Stroke Recovery
RECRUITING · NA
-
MyHand 2: An Active Hand Orthosis for Stroke Patients
RECRUITING · NA
-
Mapping Corticoreticulospinal Motor Control in Chronic Hemiparetic Stroke
RECRUITING · NA
-
Behavioral Assessment Method Index
RECRUITING
-
Human-Machine System for the H2 Lower Limb Exoskeleton
RECRUITING · NA
-
Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.